0930 ET - Humana tells analysts on its 1Q call that medical costs are running in line with its expectations and the impact of federal billing rule changes is also playing out as predicted. The company says it had no update on its closely-watched litigation aimed at fixing a huge expected decline in quality-related Medicare bonuses. Humana said it is still aiming to achieve a 3% margin on its core business in 2027. Humana is up 6% in early trading. (anna.mathews@wsj.com)
(END) Dow Jones Newswires
April 30, 2025 09:30 ET (13:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.